Citigroup Reiterates Buy on Boston Scientific, Maintains $63 Price Target
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Joanne Wuensch has reiterated a 'Buy' rating on Boston Scientific (NYSE:BSX) and maintained a price target of $63.
September 21, 2023 | 3:34 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Citigroup has reiterated a 'Buy' rating on Boston Scientific and maintained a price target of $63.
The reiteration of a 'Buy' rating by Citigroup indicates a positive outlook for Boston Scientific. The maintained price target of $63 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100